• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pancreatitis (4481); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/01/2022
Event Type  Injury  
Event Description
Olympus medical systems corp.(omsc) received a literature titled "very urgent endoscopic retrograde cholangiopancreatography is associated with early discharge in patients with non-severe acute cholangitis".Literature summary background: endoscopic retrograde cholangiopancreatography (ercp) is a first-line procedure for biliary drainage in patients with acute cholangitis, and there are no studies focused on very urgent ercp within several hours of hospital arrival.This study aimed to elucidate the use of very urgent ercp for non-severe acute cholangitis.Methods: this retrospective observational study included patients with non-severe acute cholangitis who underwent ercp between april 2011 and june 2020 in our institution.Patients were stratified into three groups based on time to ercp after hospital arrival: very urgent (= 3 hours), urgent (3-24 hours) and elective (> 24 hours).The primary outcome was length of hospital stay (los).Results: this retrospective, observational cohort study was to elucidate the use of very urgent endoscopic retrograde cholangiopancreatography (ercp) as performed within = 3 hours after hospital arrival for non-severe acute cholangitis (ac), by comparing with ercp as performed > 3 hours after hospital arrival.A total of 291 patients were included (47 patients (very urgent group), 196 patients (urgent group), and 48 patients (elective group).A shorter los was associated with earlier ercp (log-rank trend test, p = 0.04).The rates of readmission within 30 days of discharge and of adverse events were not significantly different among the three groups.The multivariate analysis showed that, compared with the very urgent group, the hrs were significantly lower in the urgent (hr, 0.71, p = 0.04) and elective (hr, 0.47, p < 0.01) groups.Very urgent ercp for non-severe acute cholangitis was associated with early discharge.Conclusions: very urgent ercp for non-severe acute cholangitis was associated with early discharge.Type of adverse events/number of patients very urgent readmission within 30 days of discharge - 3 patients pancreatitis - 3 patients acute cholecystitis - 1 patient urgent pancreatitis - 11 patients readmission within 30 days of discharge - 5 patients elective readmission within 30 days of discharge - 1 patient pancreatitis - 2 patients this literature article requires 3 reports.The related patient identifiers are as follows: 1.(b)(6)- tjf-240.2.(b)(6)- jf-260v.3.(b)(6)- tjf-q290v.This medwatch report is for (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
H6 - code 4581 is used to reflect acute cholecystitis.The suspect device has not been returned to olympus.Additional information is being requested.The literature article is attached for additional information.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation or if additional information is received.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17082969
MDR Text Key316845292
Report Number9610595-2023-08552
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/08/2023
Initial Date FDA Received06/07/2023
Supplement Dates Manufacturer Received07/07/2023
Supplement Dates FDA Received07/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-